Clinical Trials Logo

Clinical Trial Summary

This study was to test an appropriate dose of fluorescein sodium which can provide high image quality to ensure endoscopy examination and have no yellow dye in the skin by a randomized blinded controlled trial.


Clinical Trial Description

Fluorescein sodium is one of the commonly used staining agents in confocal laser endoscopy, a device for in vivo real-time histological observation of the gastrointestinal mucosa. The conventional intravenous dosage of fluorescein sodium is in the range of 5ml to 10ml of 10% fluorescein. Image quality can be guaranteed with this range of fluorescein sodium, but yellow discoloration of the skin seriously influences daily life. This study was to test whether a lower dose of fluorescein sodium, which has minimal discoloration of skin, can provide satisfied image quality by a randomized blinded controlled trial. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Screening


Related Conditions & MeSH terms


NCT number NCT02519920
Study type Interventional
Source Shandong University
Contact Yanqing Li, PhD.MD
Phone 18678827666
Email qiluliyanqing@gmail.com
Status Recruiting
Phase Phase 2
Start date April 2015
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT03425032 - Low-dose Whole Body Computed Tomography Scanning
Completed NCT03180944 - Lower Lugol's Solution Concentration on Reducing the Adverse Symptoms of Chromoendoscopy With Iodine Staining Phase 2
Completed NCT03812185 - TEE Image Quality Improvement With Our Devised Probe Cover N/A